跳至主要内容
临床试验/CTIS2023-510309-16-00
CTIS2023-510309-16-00招募中1 期

PAmidronate for Pain in Sternocostoclavicular hyperostosis: the PAPS-study, a double-blind randomized placebo-controlled trial (PAPS)

Academisch Ziekenhuis Leiden0 个研究点目标入组 70 人开始时间: 2024年7月17日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • NRS score for maximal pain of = 6/10 at lesion sites, Signs of disease activity on imaging at lesion sites, No treatment with bisphosphonates for the previous 6 months

排除标准

  • Age below 18 years of age, Mental disability, Active pregnancy wish, pregnancy or nursing, Generalized pain without CNO related pain, Bisphosphonate allergy, Estimated glomerular filtration rate < 30 ml/min, Uncontrolled endocrine abnormalities, Active cancer treatment, Language barrier, Severe co-morbidity, including poor mobility and other causes preventing attendance for control visits

研究者

相似试验